Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 79Unknown 23Recruiting 23Terminated 19Active not recruiting 17Withdrawn 7Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER_GOV 2OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 469Neoplasms 327Colorectal Neoplasms 236Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 173Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 93Recurrence 88Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 78Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 69Colonic Neoplasms 68Glioblastoma 66Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 46

Interventions

Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Uveal Melanoma × Clear all
NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Herlev Hospital

Phase 1 Not yet recruiting
15 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡